That's opposed to the $225 a month compounded product. She will still sell the commercial products, like Ozempic and Wegovy, and will continue selling an oral form of the semaglutide.

Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss copycats.